©
James Gathany / Reuters
|
Tech
giant Google, soon to be Alphabet, is considering entering the burgeoning
research area of genetic modification, beginning with the mosquito genome.
Online
portal The Information reports a top executive has met with leading experts in
the field. Linus Upson, who led the team that developed the Chrome browser, has
discussed teaming up with Harvard geneticist George Church to create mosquitoes
to wipe out diseases such as malaria, which according to the World Health Organization
(WHO) killed more than half a million people last year, and dengue fever, which
annually infects over 300 million individuals.
Church
told tech site re/code that he discussed a powerful gene-editing technique
called CRISPR with Upson and Google CEO Larry Page.
“We’re
not anticipating it will be a commercial success. It might be easier to go the
philanthropic route through the Gates Foundation or Google,” Church said.
Google
has declined to comment on the story. All reports indicate the project is still
in the planning phase, and that no facilities or scientists have been assigned
to the endeavor so far.
While
most associate genetic engineering with plants, there is history of successful
experiments modifying the mosquito genome, in which insects are injected with a
mixture of genetic material from E.coli, herpes simplex, cabbage and coral.
When released, the mosquitoes interbreed with the existing population, but due
to the genetic admixture, the larvae produced do not survive, and the entire
population diminishes.
Patients
with suspected dengue symptoms wait to see doctors in a medical tent © Paulo
Whitaker / Reuters
|
Oxitec,
a British startup that came out of Oxford University, released 70 million of
such genetically-modified mosquitoes into the wild in a series of field trials
spanning from Brazil to the Cayman Islands to Malaysia.
In
the Cayman Islands, the experiment brought down the population of a particular
mosquito species, aedes aegypti,
which spreads dengue fever, down by 96 percent.
With
dengue fever carriers spreading further and further north, a trial is planned
in an area adjacent to 400 households in Key West this year, although more than
150,000 people have petitioned the FDA to ban it.
The
petition asks: “Why would we not expect GM insects, especially those that bite
humans, to have similar unintended negative consequences? Will the more
virulent Asian tiger mosquito that also carries dengue fill the void left by
reductions in aedes aegypti? Will the
dengue virus mutate (think antibiotic resistant MRSA) and become even more
dangerous?”
It
appears that Church will not be using the same technique as Oxitec, but a more
sophisticated technology, known as CRISPR. Much more flexible, and cheaper than
traditional technologies, CRISPR may allow scientists to simply implant an
immunity to malaria or dengue fever into mosquito populations, as has already
been proven in trial lab studies.
Mosquito eggs being
injected with DNA © Oxitec
|
Church
has used his expertise to found several companies, including Editas, which this
year raised US$120 million from Bill Gates and other powerful backers for its
therapeutic gene modification treatments. Church said that the Google
initiative was not directly linked to Editas research.
While
the field remains open to experiments, the WHO has published a thick book of
guidelines for any future studies involving GM mosquitoes.
No comments :
Post a Comment